Chronic exposure to the TGF‐β promotes a stable EMT state in mammary carcinoma cells accompanied by stable generation of cancer stem cells (CSCs) and drug resistance that cannot be reversed after withdrawal of TGF‐β, but it is responsive to the mTOR inhibition.66 Here, TGFB1 is linked to breast carcinoma.